Genetic News and Research

RSS

Sangamo presents immunological data from SB-728-T HIV clinical study at CROI 2016

Sangamo BioSciences, Inc., the leader in therapeutic genome editing, announced the presentation of immunological data from the Company's clinical trials of SB-728-T, a ZFP Therapeutic designed to provide functional control of HIV.

25 Feb 2016

Four molecular subtypes of pancreatic cancer identified

Today, researchers from the Australian Pancreatic Cancer Genome Initiative published a pivotal study in the journal Nature that identified four subtypes of pancreatic cancer.

25 Feb 2016

IMP's Johannes Zuber receives German Cancer Prize 2016

Johannes Zuber, group leader at the Research Institute of Molecular Pathology (IMP) in Vienna, receives the German Cancer Prize 2016 in the category of experimental cancer research.

24 Feb 2016

Investigating mechanism behind development of high-grade serous ovarian cancer

Rutgers Cancer Institute of New Jersey researcher Michael L. Gatza, PhD, has received a $747,000 Pathway to Independence Award (R00-CA166228) from the National Cancer Institute to explore the mechanism behind the development of a subtype of ovarian cancer known as high-grade serous ovarian cancer.

24 Feb 2016

Asterias announces successful completion of End-of-Phase 2 meeting with FDA for AML therapy

Asterias Biotherapeutics, Inc. today announced the successful completion of an End-of-Phase 2 meeting with the U.S. Food and Drug Administration for AST-VAC1, its investigational therapy targeting acute myeloid leukemia (AML).

24 Feb 2016

Researchers launch clinical trials to test novel cellular-immunotherapy to treat three types of blood cancer

Cancer immunology is based upon boosting the body's own immune system to vanquish malignancies. It is among the fastest growing areas of oncology research. Researchers at UC San Diego Moores Cancer Center have launched three clinical trials to test the safety and efficacy of a novel cellular-immunotherapy that uses modified T cells - one of the immune system's primary weapons - to treat three different types of blood cancer that often defy existing therapies.

24 Feb 2016

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

24 Feb 2016

New research shows copper can destroy MRSA in touch contamination

New research from the University of Southampton shows that copper can destroy MRSA spread by touching and fingertip contamination of surfaces.

24 Feb 2016

Study reveals role of 'Kurly' protein found in cilia

A new study of a protein found in cilia - the hair-like projections on the cell surface - may help explain how genetic defects in cilia play a role in developmental abnormalities, kidney disease and a number of other disorders.

24 Feb 2016

Cells with higher fat content live longer than lean cells

Cells with higher fat content outlive lean cells, says a new study from Michigan State University.

24 Feb 2016

Study: Migraine, tension-type headaches may share genetic links with IBS

Migraine and tension-type headaches may share genetic links with irritable bowel syndrome (IBS), according to a preliminary study released today that will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016.

24 Feb 2016

Texas Children's Hospital, Houston Methodist Hospital jointly release country's first rapid test for Zika virus

Collaboration between two Texas Medical Center institutions has resulted in today's release of the country's first hospital-based rapid tests for the Zika virus.

23 Feb 2016

Diversigen, Baylor Miraca to provide customers access to targeted genomics and metabolomics services

Diversigen, Inc., the leading provider of comprehensive microbiome analysis services, today announced a strategic partnership with Baylor Miraca Genetics Laboratories, a global leader in genetic testing, to provide their customers access to a broad range of targeted genomics and metabolomics services.

23 Feb 2016

Genetic News and Research

Sangamo presents immunological data from SB-728-T HIV clinical study at CROI 2016

Four molecular subtypes of pancreatic cancer identified

IMP's Johannes Zuber receives German Cancer Prize 2016

Investigating mechanism behind development of high-grade serous ovarian cancer

Asterias announces successful completion of End-of-Phase 2 meeting with FDA for AML therapy

Researchers launch clinical trials to test novel cellular-immunotherapy to treat three types of blood cancer

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

New research shows copper can destroy MRSA in touch contamination

Study reveals role of 'Kurly' protein found in cilia

Cells with higher fat content live longer than lean cells

Study: Migraine, tension-type headaches may share genetic links with IBS

Texas Children's Hospital, Houston Methodist Hospital jointly release country's first rapid test for Zika virus

Diversigen, Baylor Miraca to provide customers access to targeted genomics and metabolomics services

Researchers Pinpoint Potential Enzyme For T-Cell Leukemia Treatment

New clinical trial focuses on respiratory drug ambroxol for treatment of Parkinson's disease

Hiroshima University researchers identify new class of cancer-causing genetic variations

UCSF study finds specific molecular-genetic mechanism that links sleep and seasonal depression

Partner's lifestyle has greater influence on obesity risk

SIFT 4G software can lead to faster genome analysis

Two Johns Hopkins scientists named among 105 winners of Presidential Early Career Awards

Genetics & Genomics - Second Edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News